Louis Akulayi

发表

Monitoring fever treatment behaviour and equitable access to effective medicines in the context of initiatives to improve ACT access: baseline results and implications for programming in six African countries

M. Littrell, C. Goodman, B. Hamainza, 2011, Malaria Journal.

Private sector opportunities and threats to achieving malaria elimination in the Greater Mekong Subregion: results from malaria outlet surveys in Cambodia, the Lao PDR, Myanmar, and Thailand

K. Bruxvoort, K. Bates, JuliAnna Z. Smith, 2017, Malaria Journal.

Got ACTs? Availability, price, market share and provider knowledge of anti-malarial medicines in public and private sector outlets in six malaria-endemic countries

C. Goodman, B. Hamainza, K. Hanson, 2011, Malaria Journal.

When it just won’t go away: oral artemisinin monotherapy in Nigeria, threatening lives, threatening progress

P. Newton, K. Bruxvoort, K. Bates, 2017, Malaria Journal.

Anti-malarial landscape in Myanmar: results from a nationally representative survey among community health workers and the private sector outlets in 2015/2016

M. Littrell, K. Bates, JuliAnna Z. Smith, 2017, Malaria Journal.

Private sector role, readiness and performance for malaria case management in Uganda, 2015

M. Littrell, K. Bruxvoort, K. Bates, 2017, Malaria Journal.

Insights into the availability and distribution of oral artemisinin monotherapy in Myanmar: evidence from a nationally representative outlet survey

M. Littrell, K. Bruxvoort, K. Bates, 2017, Malaria Journal.

Evidence on anti-malarial and diagnostic markets in Cambodia to guide malaria elimination strategies and policies

M. Littrell, K. Bruxvoort, K. Bates, 2017, Malaria Journal.

Understanding Private Sector Antimalarial Distribution Chains: A Cross-Sectional Mixed Methods Study in Six Malaria-Endemic Countries

I. Kleinschmidt, C. Goodman, K. O’Connell, 2014, PloS one.

Do anti-malarials in Africa meet quality standards? The market penetration of non quality-assured artemisinin combination therapy in eight African countries

P. Newton, M. Littrell, K. Bruxvoort, 2017, Malaria Journal.

Prices and mark-ups on antimalarials: evidence from nationally representative studies in six malaria-endemic countries

I. Kleinschmidt, C. Goodman, K. O’Connell, 2015, Health policy and planning.

OP-HEAP150032 1..13

I. Kleinschmidt, C. Goodman, K. O’Connell, 2015 .

The malaria testing and treatment landscape in Kenya: results from a nationally representative survey among the public and private sector in 2016

M. Littrell, K. Bruxvoort, K. Bates, 2017, Malaria Journal.

Testing times: trends in availability, price, and market share of malaria diagnostics in the public and private healthcare sector across eight sub-Saharan African countries from 2009 to 2015

M. Littrell, K. Bruxvoort, C. Goodman, 2017, Malaria Journal.

What happened to anti-malarial markets after the Affordable Medicines Facility-malaria pilot? Trends in ACT availability, price and market share from five African countries under continuation of the private sector co-payment mechanism

M. Littrell, K. Bruxvoort, C. Goodman, 2017, Malaria Journal.

The malaria testing and treatment landscape in mainland Tanzania, 2016

M. Littrell, K. Bruxvoort, K. Bates, 2017, Malaria Journal.

The malaria testing and treatment landscape in Benin

M. Littrell, K. Bruxvoort, K. Bates, 2017, Malaria Journal.

Do anti-malarials in Africa meet quality standards? The market penetration of non quality-assured artemisinin combination therapy in eight African countries

P. Newton, K. Bruxvoort, C. Goodman, 2017, Malaria Journal.